BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19048929)

  • 21. Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL.
    Pfitzenmaier J; Gilfrich C; Pritsch M; Herrmann D; Buse S; Haferkamp A; Djakovic N; Pahernik S; Hohenfellner M
    BJU Int; 2008 Aug; 102(3):322-7. PubMed ID: 18422772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technique and short-term outcome of green light laser (KTP, 80W) vaporisation of the prostate.
    Heinrich E; Schiefelbein F; Schoen G
    Eur Urol; 2007 Dec; 52(6):1632-7. PubMed ID: 17689002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Holmium laser ablation versus photoselective vaporization of prostate less than 60 cc: long-term results of a randomized trial.
    Elmansy HM; Elzayat E; Elhilali MM
    J Urol; 2010 Nov; 184(5):2023-8. PubMed ID: 20850828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experiences in the treatment of benign prostatic hyperplasia with high power potassium-titanyl-phosphate (KTP) laser].
    Lipiński MI; Peszyński-Drews C; Jeromin MZ; Jeromin LM
    Wiad Lek; 2006; 59(3-4):196-8. PubMed ID: 16813263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention.
    Monoski MA; Gonzalez RR; Sandhu JS; Reddy B; Te AE
    Urology; 2006 Aug; 68(2):312-7. PubMed ID: 16904443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial.
    Horasanli K; Silay MS; Altay B; Tanriverdi O; Sarica K; Miroglu C
    Urology; 2008 Feb; 71(2):247-51. PubMed ID: 18308094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High power potassium-titanyl-phosphate laser vaporization prostatectomy.
    Malek RS; Kuntzman RS; Barrett DM
    J Urol; 2000 Jun; 163(6):1730-3. PubMed ID: 10799170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Photoselective vaporization of the prostate (PVP) using 80 watt high power potassium-titanyl-phosphate (KTP) laser for benign prostatic hyperplasia: the first fifty-seven patients in Japan].
    Kuromatsu I; Imamura T; Sugimura Y
    Nihon Hinyokika Gakkai Zasshi; 2006 Nov; 97(7):815-22. PubMed ID: 17154023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Hamann MF; Naumann CM; Seif C; van der Horst C; Jünemann KP; Braun PM
    Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictability of irritative voiding symptoms following photoselective laser vaporization of the prostate.
    Matoka DJ; Averch TD
    Can J Urol; 2007 Oct; 14(5):3710-4. PubMed ID: 17949529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A comparative study on the photoselective vaporization of the prostate and transurethral electrovaporization resection of prostate for the treatment of benign prostatic hyperplasia].
    Yang Y; Hong BF; Fu WJ; Xu Y; Chen YF; Zhang CE
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):951-3. PubMed ID: 17961377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can we predict the outcome of 532 nm laser photoselective vaporization of the prostate? Time to event analysis.
    Elshal AM; Elmansy HM; Elhilali MM
    J Urol; 2012 Nov; 188(5):1746-53. PubMed ID: 22998906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased efficiency of potassium-titanyl-phosphate laser photoselective vaporization prostatectomy with long-term 5 alpha-reductase inhibition therapy: is it true?
    Araki M; Lam PN; Culkin DJ; Wong C
    Urology; 2007 Nov; 70(5):927-30. PubMed ID: 18068449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia.
    Ruszat R; Seitz M; Wyler SF; Müller G; Rieken M; Bonkat G; Gasser TC; Reich O; Bachmann A
    BJU Int; 2009 Sep; 104(6):820-5. PubMed ID: 19239441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80ml: 12-mo results of a randomized prospective study.
    Alivizatos G; Skolarikos A; Chalikopoulos D; Papachristou C; Sopilidis O; Dellis A; Kastriotis I; Deliveliotis C
    Eur Urol; 2008 Aug; 54(2):427-37. PubMed ID: 18069117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of photoselective vaporization and standard transurethral resection of the prostate on urodynamics in patients with benign prostatic hyperplasia.
    Nomura H; Seki N; Yamaguchi A; Naito S
    Int J Urol; 2009 Aug; 16(8):657-62. PubMed ID: 19602003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of photoselective vaporization of the prostate using the 180-W GreenLight XPS laser system in patients taking oral anticoagulants.
    Eken A; Soyupak B
    J Int Med Res; 2018 Mar; 46(3):1230-1237. PubMed ID: 29332492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Holmium laser enucleation of the prostate in patients on anticoagulant therapy or with bleeding disorders.
    Elzayat E; Habib E; Elhilali M
    J Urol; 2006 Apr; 175(4):1428-32. PubMed ID: 16516015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia.
    Chung DE; Wysock JS; Lee RK; Melamed SR; Kaplan SA; Te AE
    J Urol; 2011 Sep; 186(3):977-81. PubMed ID: 21791350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potassium-titanyl-phosphate laser photoselective vaporization for benign prostatic hyperplasia: 5-year follow-up from a district general hospital.
    Malde S; Rajagopalan A; Patel N; Simoes A; Choi W; Shrotri N
    J Endourol; 2012 Jul; 26(7):878-83. PubMed ID: 22260554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.